This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. (MRNA) inched 0.06% higher to $305.10 Monday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 0.64% to 14,486.20 and Dow Jones Industrial Average falling 0.72% to 34,496.06. Moderna Inc. closed $192.39 short of its 52-week high ($497.49), which the company reached on August 10th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) fell 0.76% to $110.34, Amgen Inc. (AMGN) fell 1.08% to $206.70, and AstraZeneca PLC ADR (AZN.LN) rose 0.31% to $60.80. Trading volume (7.6 M) remained 10.0 million below its 50-day average volume of 17.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled October 11, 2021.
(END) Dow Jones Newswires
October 11, 2021 16:31 ET (20:31 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.